Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Country/Region, 2017, 2022 & 2028

2.2 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Segment by Type

2.2.1 Vials

2.2.2 Prefilled

2.3 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type

2.3.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Type (2017-2022)

2.3.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sale Price by Type (2017-2022)

2.4 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Segment by Application

2.4.1 Myelosuppressive Chemotherapy

2.4.2 Leukemia Chemotherapy

2.4.3 Others

2.5 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application

2.5.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sale Market Share by Application (2017-2022)

2.5.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sale Price by Application (2017-2022)

3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Company

3.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Breakdown Data by Company

3.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Annual Sales by Company (2020-2022)

3.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Company (2020-2022)

3.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Annual Revenue by Company (2020-2022)

3.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Company (2020-2022)

3.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Company (2020-2022)

3.3 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sale Price by Company

3.4 Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Location Distribution

3.4.2 Players Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Geographic Region

4.1 World Historic Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Geographic Region (2017-2022)

4.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Annual Revenue by Geographic Region

4.2 World Historic Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size by Country/Region (2017-2022)

4.2.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Annual Revenue by Country/Region

4.3 Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Growth

4.4 APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Growth

4.5 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Growth

4.6 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Growth

5 Americas

5.1 Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country

5.1.1 Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2017-2022)

5.1.2 Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2017-2022)

5.2 Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type

5.3 Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region

6.1.1 APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2017-2022)

6.1.2 APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2017-2022)

6.2 APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type

6.3 APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Country

7.1.1 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2017-2022)

7.1.2 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2017-2022)

7.2 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type

7.3 Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Country

8.1.1 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2017-2022)

8.2 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type

8.3 Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF)

10.3 Manufacturing Process Analysis of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF)

10.4 Industry Chain Structure of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Distributors

11.3 Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Customer

12 World Forecast Review for Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) by Geographic Region

12.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Size Forecast by Region

12.1.1 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Forecast by Region (2023-2028)

12.1.2 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Forecast by Type

12.7 Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Forecast by Application

13 Key Players Analysis

13.1 Abbott

13.1.1 Abbott Company Information

13.1.2 Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.1.3 Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Abbott Main Business Overview

13.1.5 Abbott Latest Developments

13.2 Amgen

13.2.1 Amgen Company Information

13.2.2 Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.2.3 Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Amgen Main Business Overview

13.2.5 Amgen Latest Developments

13.3 Arven Pharmaceuticals

13.3.1 Arven Pharmaceuticals Company Information

13.3.2 Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.3.3 Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Arven Pharmaceuticals Main Business Overview

13.3.5 Arven Pharmaceuticals Latest Developments

13.4 Biocon

13.4.1 Biocon Company Information

13.4.2 Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.4.3 Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Biocon Main Business Overview

13.4.5 Biocon Latest Developments

13.5 Cadila Pharmaceuticals

13.5.1 Cadila Pharmaceuticals Company Information

13.5.2 Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.5.3 Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Cadila Pharmaceuticals Main Business Overview

13.5.5 Cadila Pharmaceuticals Latest Developments

13.6 Dr.Reddy's Laboratories

13.6.1 Dr.Reddy's Laboratories Company Information

13.6.2 Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.6.3 Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Dr.Reddy's Laboratories Main Business Overview

13.6.5 Dr.Reddy's Laboratories Latest Developments

13.7 Emcure Pharmaceuticals

13.7.1 Emcure Pharmaceuticals Company Information

13.7.2 Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.7.3 Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Emcure Pharmaceuticals Main Business Overview

13.7.5 Emcure Pharmaceuticals Latest Developments

13.8 Intas Pharmaceuticals

13.8.1 Intas Pharmaceuticals Company Information

13.8.2 Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.8.3 Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Intas Pharmaceuticals Main Business Overview

13.8.5 Intas Pharmaceuticals Latest Developments

13.9 Kyowa Kirin

13.9.1 Kyowa Kirin Company Information

13.9.2 Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.9.3 Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Kyowa Kirin Main Business Overview

13.9.5 Kyowa Kirin Latest Developments

13.10 Novartis

13.10.1 Novartis Company Information

13.10.2 Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.10.3 Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Novartis Main Business Overview

13.10.5 Novartis Latest Developments

13.11 Pfizer

13.11.1 Pfizer Company Information

13.11.2 Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.11.3 Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Pfizer Main Business Overview

13.11.5 Pfizer Latest Developments

13.12 Reliance Life Sciences

13.12.1 Reliance Life Sciences Company Information

13.12.2 Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.12.3 Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Reliance Life Sciences Main Business Overview

13.12.5 Reliance Life Sciences Latest Developments

13.13 Harbin Pharmaceutical

13.13.1 Harbin Pharmaceutical Company Information

13.13.2 Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.13.3 Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Harbin Pharmaceutical Main Business Overview

13.13.5 Harbin Pharmaceutical Latest Developments

13.14 North China Pharmaceutical

13.14.1 North China Pharmaceutical Company Information

13.14.2 North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.14.3 North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 North China Pharmaceutical Main Business Overview

13.14.5 North China Pharmaceutical Latest Developments

13.15 Jiuyuan Gene

13.15.1 Jiuyuan Gene Company Information

13.15.2 Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.15.3 Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Jiuyuan Gene Main Business Overview

13.15.5 Jiuyuan Gene Latest Developments

13.16 Kexing Biopharm

13.16.1 Kexing Biopharm Company Information

13.16.2 Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.16.3 Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Kexing Biopharm Main Business Overview

13.16.5 Kexing Biopharm Latest Developments

13.17 Qilu Pharmaceutical

13.17.1 Qilu Pharmaceutical Company Information

13.17.2 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.17.3 Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Qilu Pharmaceutical Main Business Overview

13.17.5 Qilu Pharmaceutical Latest Developments

13.18 Quangang Pharmaceutical

13.18.1 Quangang Pharmaceutical Company Information

13.18.2 Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.18.3 Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Quangang Pharmaceutical Main Business Overview

13.18.5 Quangang Pharmaceutical Latest Developments

13.19 Sunway Biotech

13.19.1 Sunway Biotech Company Information

13.19.2 Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.19.3 Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Sunway Biotech Main Business Overview

13.19.5 Sunway Biotech Latest Developments

13.20 SL Pharmaceutical

13.20.1 SL Pharmaceutical Company Information

13.20.2 SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.20.3 SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 SL Pharmaceutical Main Business Overview

13.20.5 SL Pharmaceutical Latest Developments

13.21 Four Rings Bio-Pharmaceutical

13.21.1 Four Rings Bio-Pharmaceutical Company Information

13.21.2 Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.21.3 Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Four Rings Bio-Pharmaceutical Main Business Overview

13.21.5 Four Rings Bio-Pharmaceutical Latest Developments

13.22 Amoytop

13.22.1 Amoytop Company Information

13.22.2 Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.22.3 Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Amoytop Main Business Overview

13.22.5 Amoytop Latest Developments

13.23 Wuzhong Pharmaceutical

13.23.1 Wuzhong Pharmaceutical Company Information

13.23.2 Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

13.23.3 Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Wuzhong Pharmaceutical Main Business Overview

13.23.5 Wuzhong Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Vials

Table 4. Major Players of Prefilled

Table 5. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2017-2022) & (K L)

Table 6. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Type (2017-2022)

Table 7. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Type (2017-2022) & ($ million)

Table 8. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Type (2017-2022)

Table 9. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sale Price by Type (2017-2022) & (US$/L)

Table 10. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2017-2022) & (K L)

Table 11. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Application (2017-2022)

Table 12. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Application (2017-2022)

Table 13. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Application (2017-2022)

Table 14. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sale Price by Application (2017-2022) & (US$/L)

Table 15. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Company (2020-2022) & (K L)

Table 16. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Company (2020-2022)

Table 17. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Company (2020-2022)

Table 19. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sale Price by Company (2020-2022) & (US$/L)

Table 20. Key Manufacturers Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Producing Area Distribution and Sales Area

Table 21. Players Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Products Offered

Table 22. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Geographic Region (2017-2022) & (K L)

Table 26. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share Geographic Region (2017-2022)

Table 27. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country/Region (2017-2022) & (K L)

Table 30. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Country/Region (2017-2022)

Table 31. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2017-2022) & (K L)

Table 34. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Country (2017-2022)

Table 35. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Country (2017-2022)

Table 37. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2017-2022) & (K L)

Table 38. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Type (2017-2022)

Table 39. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2017-2022) & (K L)

Table 40. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Application (2017-2022)

Table 41. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2017-2022) & (K L)

Table 42. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Region (2017-2022)

Table 43. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Region (2017-2022)

Table 45. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2017-2022) & (K L)

Table 46. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Type (2017-2022)

Table 47. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2017-2022) & (K L)

Table 48. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Application (2017-2022)

Table 49. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2017-2022) & (K L)

Table 50. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Country (2017-2022)

Table 51. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Country (2017-2022)

Table 53. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2017-2022) & (K L)

Table 54. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Type (2017-2022)

Table 55. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2017-2022) & (K L)

Table 56. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Country (2017-2022) & (K L)

Table 58. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Type (2017-2022) & (K L)

Table 62. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Application (2017-2022) & (K L)

Table 64. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF)

Table 66. Key Market Challenges & Risks of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF)

Table 67. Key Industry Trends of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF)

Table 68. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Distributors List

Table 71. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Customer List

Table 72. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Forecast by Region (2023-2028) & (K L)

Table 73. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Forecast by Region

Table 74. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Forecast by Country (2023-2028) & (K L)

Table 77. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Forecast by Region (2023-2028) & (K L)

Table 79. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Forecast by Country (2023-2028) & (K L)

Table 81. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Forecast by Country (2023-2028) & (K L)

Table 83. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Forecast by Type (2023-2028) & (K L)

Table 85. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Forecast by Application (2023-2028) & (K L)

Table 89. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share Forecast by Application (2023-2028)

Table 92. Abbott Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 93. Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 94. Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 95. Abbott Main Business

Table 96. Abbott Latest Developments

Table 97. Amgen Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 98. Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 99. Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 100. Amgen Main Business

Table 101. Amgen Latest Developments

Table 102. Arven Pharmaceuticals Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 103. Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 104. Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 105. Arven Pharmaceuticals Main Business

Table 106. Arven Pharmaceuticals Latest Developments

Table 107. Biocon Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 108. Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 109. Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 110. Biocon Main Business

Table 111. Biocon Latest Developments

Table 112. Cadila Pharmaceuticals Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 113. Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 114. Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 115. Cadila Pharmaceuticals Main Business

Table 116. Cadila Pharmaceuticals Latest Developments

Table 117. Dr.Reddy's Laboratories Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 118. Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 119. Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 120. Dr.Reddy's Laboratories Main Business

Table 121. Dr.Reddy's Laboratories Latest Developments

Table 122. Emcure Pharmaceuticals Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 123. Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 124. Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 125. Emcure Pharmaceuticals Main Business

Table 126. Emcure Pharmaceuticals Latest Developments

Table 127. Intas Pharmaceuticals Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 128. Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 129. Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 130. Intas Pharmaceuticals Main Business

Table 131. Intas Pharmaceuticals Latest Developments

Table 132. Kyowa Kirin Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 133. Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 134. Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 135. Kyowa Kirin Main Business

Table 136. Kyowa Kirin Latest Developments

Table 137. Novartis Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 138. Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 139. Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 140. Novartis Main Business

Table 141. Novartis Latest Developments

Table 142. Pfizer Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 143. Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 144. Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 145. Pfizer Main Business

Table 146. Pfizer Latest Developments

Table 147. Reliance Life Sciences Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 148. Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 149. Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 150. Reliance Life Sciences Main Business

Table 151. Reliance Life Sciences Latest Developments

Table 152. Harbin Pharmaceutical Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 153. Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 154. Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 155. Harbin Pharmaceutical Main Business

Table 156. Harbin Pharmaceutical Latest Developments

Table 157. North China Pharmaceutical Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 158. North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 159. North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 160. North China Pharmaceutical Main Business

Table 161. North China Pharmaceutical Latest Developments

Table 162. Jiuyuan Gene Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 163. Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 164. Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 165. Jiuyuan Gene Main Business

Table 166. Jiuyuan Gene Latest Developments

Table 167. Kexing Biopharm Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 168. Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 169. Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 170. Kexing Biopharm Main Business

Table 171. Kexing Biopharm Latest Developments

Table 172. Qilu Pharmaceutical Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 173. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 174. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 175. Qilu Pharmaceutical Main Business

Table 176. Qilu Pharmaceutical Latest Developments

Table 177. Quangang Pharmaceutical Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 178. Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 179. Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 180. Quangang Pharmaceutical Main Business

Table 181. Quangang Pharmaceutical Latest Developments

Table 182. Sunway Biotech Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 183. Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 184. Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 185. Sunway Biotech Main Business

Table 186. Sunway Biotech Latest Developments

Table 187. SL Pharmaceutical Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 188. SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 189. SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 190. SL Pharmaceutical Main Business

Table 191. SL Pharmaceutical Latest Developments

Table 192. Four Rings Bio-Pharmaceutical Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 193. Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 194. Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 195. Four Rings Bio-Pharmaceutical Main Business

Table 196. Four Rings Bio-Pharmaceutical Latest Developments

Table 197. Amoytop Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 198. Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 199. Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 200. Amoytop Main Business

Table 201. Amoytop Latest Developments

Table 202. Wuzhong Pharmaceutical Basic Information, Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturing Base, Sales Area and Its Competitors

Table 203. Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Product Offered

Table 204. Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)

Table 205. Wuzhong Pharmaceutical Main Business

Table 206. Wuzhong Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF)

Figure 2. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Growth Rate 2017-2028 (K L)

Figure 7. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Vials

Figure 10. Product Picture of Prefilled

Figure 11. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Type in 2021

Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Type (2017-2022)

Figure 13. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumed in Myelosuppressive Chemotherapy

Figure 14. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market: Myelosuppressive Chemotherapy (2017-2022) & (K L)

Figure 15. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumed in Leukemia Chemotherapy

Figure 16. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market: Leukemia Chemotherapy (2017-2022) & (K L)

Figure 17. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumed in Others

Figure 18. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market: Others (2017-2022) & (K L)

Figure 19. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Application (2017-2022)

Figure 20. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Application in 2021

Figure 21. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Company in 2021

Figure 23. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Geographic Region in 2021

Figure 25. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Region (2017-2022)

Figure 26. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Country/Region in 2021

Figure 27. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales 2017-2022 (K L)

Figure 28. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue 2017-2022 ($ Millions)

Figure 29. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales 2017-2022 (K L)

Figure 30. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue 2017-2022 ($ Millions)

Figure 31. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales 2017-2022 (K L)

Figure 32. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales 2017-2022 (K L)

Figure 34. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue 2017-2022 ($ Millions)

Figure 35. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Country in 2021

Figure 36. Americas Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share by Country in 2021

Figure 37. United States Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Market Share by Region in 2021

Figure 42. APAC Recombinant Human Granulocyte Colony-Stimulating Factor Inject